Proposed Rules

  • Mammography Quality Standards Act
  • Radiological Health Regulations; Amendments to Records and Reports for Radiation Emitting Electronic Products; Amendments to Performance Standards for Diagnostic X-Ray, Laser and Ultrasonic Products
  • Basic Health Program; Federal Funding Methodology for Program Years 2019 and 2020
  • Patient Protection and Affordable Care Act; Increasing Consumer Choice Through the Sale of Individual Health Insurance Coverage Across State Lines Through Health Care Choice Compacts
  • Medicare Program; Release of Data Underlying Risk Adjustment Data Validation Provisions
  • Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability and Patient Access for Medicare Advantage Organization and Medicaid Managed Care Plans, State Medicaid Agencies, CHIP Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans in the Federally-Facilitated Exchanges and Health Care Providers
  • Medicare, Medicaid, and Children Health Insurance Programs; Program Integrity Enhancements to the Provider Enrollment Process; Extension of Timeline for Publication of the Final Rule
  • World Trade Center Health Program; Petition 020-Stroke; Finding of Insufficient Evidence
  • Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
  • Clinical Laboratory Improvement Amendments of 1988 (CLIA) Proficiency Testing Regulations Related to Analytes and Acceptable Performance
  • Medicare Program: Accrediting Organizations Conflict of Interest and Consulting Services; Request for Information
  • Modernizing Part D and Medicare Advantage To Lower Drug Prices and Reduce Out-of-Pocket Expenses
  • Medicaid Program; Medicaid and Childrens Health Insurance Plan (CHIP) Managed Care
  • Medicare and Medicaid Programs; Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Program of All-Inclusive Care for the Elderly (PACE), Medicaid Fee-for-Service, and Medicaid Managed Care Programs for Years 2020 and 2021
  • Medicare Program; International Pricing Index Model for Medicare Part B Drugs
  • Medicare and Medicaid Programs; Regulation To Require Drug Pricing Transparency
  • Medicare Program: Changes to the Medicare Claims and Medicare Prescription Drug Coverage Determination Appeals Procedures
  • Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction
  • Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Anti-Kickback Statute and Beneficiary Inducements CMP
  • Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations-Pathways to Success
Showing 61 to 80 of 192 results
<< < 2 3 4 5 6 > >>